Abstract
Airway epithelium (AE) lines the conducting airways of the respiratory system and functions to maintain airway integrity by providing both a physical barrier to inhaled noxious agents and a mechanism for their clearance via the mucociliary escalator. Normal AE cells are relatively refractory to a number of apoptotic stimuli and survival mechanisms are in place to maintain the integrity of the epithelial barrier that is exposed to agents such as reactive oxygen species (ROS) and death receptor ligands secreted by immune cells during inflammation. When damage to AE does occur, there is increased AE apoptosis, such as in the airway damage that occurs in the chronically inflamed airways in diseases like asthma where rates of AE apoptosis can be increased many-fold. The usual treatment for persistent asthma in humans involves a combination of bronchodilator and inhaled corticosteroid; there is however a need to develop strategies to better control other aspects of the disease, including minimizing the ongoing damage to AE and consequent airway remodeling. Targeting of the major apoptosis-regulatory factors in AE may be one such strategy. Here we review what is known about apoptosis and its regulatory factors in normal AE and abnormalities in these factors in the inflamed airways of mice and humans.
Keywords: Airway epithelium, Apoptosis, Necrosis, Airway damage, Inflammation, Asthma, Caspases, Therapy
Current Molecular Pharmacology
Title: Apoptosis-Regulatory Factors as Potential Drug Targets in the Epithelium of Normal and Inflamed Airways
Volume: 1
Author(s): P. D. Zalewski and R. E. Ruffin
Affiliation:
Keywords: Airway epithelium, Apoptosis, Necrosis, Airway damage, Inflammation, Asthma, Caspases, Therapy
Abstract: Airway epithelium (AE) lines the conducting airways of the respiratory system and functions to maintain airway integrity by providing both a physical barrier to inhaled noxious agents and a mechanism for their clearance via the mucociliary escalator. Normal AE cells are relatively refractory to a number of apoptotic stimuli and survival mechanisms are in place to maintain the integrity of the epithelial barrier that is exposed to agents such as reactive oxygen species (ROS) and death receptor ligands secreted by immune cells during inflammation. When damage to AE does occur, there is increased AE apoptosis, such as in the airway damage that occurs in the chronically inflamed airways in diseases like asthma where rates of AE apoptosis can be increased many-fold. The usual treatment for persistent asthma in humans involves a combination of bronchodilator and inhaled corticosteroid; there is however a need to develop strategies to better control other aspects of the disease, including minimizing the ongoing damage to AE and consequent airway remodeling. Targeting of the major apoptosis-regulatory factors in AE may be one such strategy. Here we review what is known about apoptosis and its regulatory factors in normal AE and abnormalities in these factors in the inflamed airways of mice and humans.
Export Options
About this article
Cite this article as:
Zalewski D. P. and Ruffin E. R., Apoptosis-Regulatory Factors as Potential Drug Targets in the Epithelium of Normal and Inflamed Airways, Current Molecular Pharmacology 2008; 1 (1) . https://dx.doi.org/10.2174/1874467210801010038
DOI https://dx.doi.org/10.2174/1874467210801010038 |
Print ISSN 1874-4672 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4702 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Breast-Milk Characteristics Protecting Against Allergy
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial [Hot Topic: Molecular Targets in Chronic Obstructive Airway Diseases (Guest Editors: David A. Groneberg and Tobias Welte)]
Current Drug Targets Novel Anti-inflammatory Drugs from Marine Microbes
The Natural Products Journal Synthesis and Biological Potential Assessment of 2-Substituted Quinazolin-4(3<i>H</i>)-ones as Inhibitors of Phosphodiesterase-I and Carbonic Anhydrase-II
Medicinal Chemistry Automated Electrophysiology in Drug Discovery
Current Pharmaceutical Design Patent Annotations
Recent Patents on Inflammation & Allergy Drug Discovery Controversies in Glaucoma: Current Medical Treatment and Drug Development
Current Pharmaceutical Design Anti-inflammatory Potential of GSK-3 Inhibitors
Current Drug Targets Editorial [Hot Topic: N-Acetyltransferases: Lessons Learned from Eighty Years of Research (Guest Editor: Jose A.G. Agundez) ]
Current Drug Metabolism Indian Indigenous Fruits as Radioprotective Agents: Past, Present and Future
Anti-Cancer Agents in Medicinal Chemistry Primaquine Loaded Chitosan Nanoparticles For Liver Targeting
Pharmaceutical Nanotechnology Therapeutic Use of Molecules that Mimic Pathogen Danger Signals
Endocrine, Metabolic & Immune Disorders - Drug Targets Phage Display Derived Therapeutic Antibodies
Current Pharmaceutical Biotechnology Phytochemistry and Pharmacological Update on Tetraterpenoids
The Natural Products Journal Tobacco Smoke Exposure, Nicotine, and the Embryologic Origins of Asthma
Current Respiratory Medicine Reviews The Anti-Inflammatory Role of Annexin-1 in Arthritis
Current Rheumatology Reviews Occupational Exposure and COPD
Current Respiratory Medicine Reviews MIF and the Genetic Basis of Macrophage Responsiveness
Current Immunology Reviews (Discontinued) Editorial from Guest Editor [Hot Topic:Vitamin D and Respiratory Health (Guest Editor: Adrian R. Martineau)]
Current Respiratory Medicine Reviews Recent Progress in the Design of Selectin Inhibitors
Mini-Reviews in Medicinal Chemistry